MD Anderson

Category

First Patient Treated in Phase 1 Study Involving Cord Blood-derived Natural Killer Cells in Combo with AFM13 (Innate Cell Engager)

Humans may have an innate ability to fight off cancer and one of the world’s most prominent research centers, University of Texas MD Anderson Cancer Center, recently co-developed a novel regenerative therapy to tap into and actually harness this power to hopefully...

MD Anderson Hosts Biden Cancer Community Summit

The University of Texas MD and Cancer Center joined more than 450 communities and institutions from across the United States to host the Biden Cancer Community Summit on Friday.  The summit's purpose is to encourage discussion about ongoing cancer research, diagnosis,...

Genprex Extends Licenses from MD Anderson

Genprex (NASDAQ:GNPX) has entered into amendments with The University of Texas MD Anderson Cancer Center to extend the terms of two option agreements pertaining the use of TUSC2, the active agent in Genprex’s Oncoprex, in combination with immunotherapies and the...

Pin It on Pinterest